

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.53512303 |
| 2 | exogenous drug catabolic process (GO:0042738) | 8.37726319 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.32935905 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62590647 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.62590647 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.30415610 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.30415610 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.84156189 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.45618331 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.17485575 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.17485575 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.17485575 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.04007438 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.97042593 |
| 15 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.84801614 |
| 16 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.84801614 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.80546821 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.78422050 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.71320017 |
| 20 | urea metabolic process (GO:0019627) | 5.69081012 |
| 21 | urea cycle (GO:0000050) | 5.69081012 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.65314697 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.63915168 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.44486021 |
| 25 | protein carboxylation (GO:0018214) | 5.43721183 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.43721183 |
| 27 | drug metabolic process (GO:0017144) | 5.43170928 |
| 28 | complement activation, alternative pathway (GO:0006957) | 5.38650819 |
| 29 | cysteine metabolic process (GO:0006534) | 5.34902788 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.34099504 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.33995238 |
| 32 | ethanol metabolic process (GO:0006067) | 5.24480327 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.23692842 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.12205058 |
| 35 | bile acid metabolic process (GO:0008206) | 5.11327630 |
| 36 | acute-phase response (GO:0006953) | 5.01076808 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.97761562 |
| 38 | regulation of complement activation (GO:0030449) | 4.96909517 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.96605504 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.94357505 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.92413442 |
| 42 | oxidative demethylation (GO:0070989) | 4.90533414 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.88966618 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.82044172 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.82044172 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.82044172 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.81389988 |
| 48 | phospholipid efflux (GO:0033700) | 4.67893737 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.67124707 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.64825588 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.64825588 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.64660743 |
| 53 | regulation of humoral immune response (GO:0002920) | 4.64492806 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.63813167 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.63813167 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.63639602 |
| 57 | lysine catabolic process (GO:0006554) | 4.56987758 |
| 58 | lysine metabolic process (GO:0006553) | 4.56987758 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 4.56767806 |
| 60 | glycine metabolic process (GO:0006544) | 4.42418774 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 4.41542118 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.41473587 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.40870819 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 4.39697971 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.36512992 |
| 66 | regulation of plasminogen activation (GO:0010755) | 4.29064421 |
| 67 | S-adenosylmethionine metabolic process (GO:0046500) | 4.27630388 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.26636370 |
| 69 | amine catabolic process (GO:0009310) | 4.26636370 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 4.26111416 |
| 71 | glutamate metabolic process (GO:0006536) | 4.25490442 |
| 72 | cholesterol efflux (GO:0033344) | 4.24622454 |
| 73 | cellular glucuronidation (GO:0052695) | 4.21457732 |
| 74 | serine family amino acid metabolic process (GO:0009069) | 4.15091299 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 4.12112070 |
| 76 | ethanol oxidation (GO:0006069) | 4.10304634 |
| 77 | plasma lipoprotein particle assembly (GO:0034377) | 4.07350801 |
| 78 | phenylpropanoid metabolic process (GO:0009698) | 4.06979533 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06924529 |
| 80 | arginine metabolic process (GO:0006525) | 4.03518312 |
| 81 | killing of cells of other organism (GO:0031640) | 4.02099458 |
| 82 | disruption of cells of other organism (GO:0044364) | 4.02099458 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 4.01551504 |
| 84 | fibrinolysis (GO:0042730) | 4.01373756 |
| 85 | aldehyde catabolic process (GO:0046185) | 3.99496605 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.99303646 |
| 87 | ketone body metabolic process (GO:1902224) | 3.95249847 |
| 88 | blood coagulation, intrinsic pathway (GO:0007597) | 3.94079377 |
| 89 | drug catabolic process (GO:0042737) | 3.93772104 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 3.93510791 |
| 91 | negative regulation of protein activation cascade (GO:2000258) | 3.93135023 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.85875189 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.85875189 |
| 94 | cofactor catabolic process (GO:0051187) | 3.82811487 |
| 95 | complement activation, classical pathway (GO:0006958) | 3.80548316 |
| 96 | negative regulation of lipase activity (GO:0060192) | 3.78176516 |
| 97 | acute inflammatory response (GO:0002526) | 3.78146573 |
| 98 | protein activation cascade (GO:0072376) | 3.77809475 |
| 99 | complement activation (GO:0006956) | 3.77627769 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.76818732 |
| 101 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76773641 |
| 102 | negative regulation of blood coagulation (GO:0030195) | 3.76241488 |
| 103 | negative regulation of hemostasis (GO:1900047) | 3.76241488 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.74199837 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.74085380 |
| 106 | carboxylic acid catabolic process (GO:0046395) | 3.73781950 |
| 107 | organic acid catabolic process (GO:0016054) | 3.73781950 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.72219913 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.72219913 |
| 110 | phospholipid homeostasis (GO:0055091) | 3.70471774 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 3.67644664 |
| 112 | sterol homeostasis (GO:0055092) | 3.67629667 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.67379241 |
| 114 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.67213240 |
| 115 | protein-lipid complex assembly (GO:0065005) | 3.66834497 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63781630 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 3.63047613 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.62371254 |
| 119 | cytolysis (GO:0019835) | 3.60067395 |
| 120 | opsonization (GO:0008228) | 3.59652567 |
| 121 | NAD biosynthetic process (GO:0009435) | 3.56620849 |
| 122 | alkaloid metabolic process (GO:0009820) | 3.52267094 |
| 123 | heme transport (GO:0015886) | 3.45042146 |
| 124 | positive regulation of hemostasis (GO:1900048) | 3.41425939 |
| 125 | positive regulation of blood coagulation (GO:0030194) | 3.41425939 |
| 126 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.39640774 |
| 127 | negative regulation of coagulation (GO:0050819) | 3.36728102 |
| 128 | regulation of acute inflammatory response (GO:0002673) | 3.28135435 |
| 129 | negative regulation of wound healing (GO:0061045) | 3.24963842 |
| 130 | regulation of apoptotic cell clearance (GO:2000425) | 3.23954897 |
| 131 | detection of bacterium (GO:0016045) | 3.22202681 |
| 132 | negative regulation of complement activation (GO:0045916) | 3.13511316 |
| 133 | positive regulation of coagulation (GO:0050820) | 3.10130121 |
| 134 | detection of other organism (GO:0098543) | 3.07561975 |
| 135 | oxaloacetate metabolic process (GO:0006107) | 3.06183752 |
| 136 | sodium-independent organic anion transport (GO:0043252) | 3.01610765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42216019 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19432072 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07933005 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50830725 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29373594 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.12533200 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80019975 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.03360222 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93450530 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.39007037 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04953664 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9591793 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92917591 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89835980 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86372129 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79658260 |
| 17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.78456898 |
| 18 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76807694 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.75135619 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72539379 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57403140 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.57127905 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56053424 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55445003 |
| 25 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53888416 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46572926 |
| 27 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45761618 |
| 28 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42547008 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40218351 |
| 30 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37840051 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32093470 |
| 32 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30787693 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30602578 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28905340 |
| 35 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.24500239 |
| 36 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.23077750 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16160253 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14432707 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14425252 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14417847 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14229577 |
| 42 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13911841 |
| 43 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.13291650 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12631155 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12018722 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.11381695 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11299538 |
| 48 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10569382 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09385935 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06264899 |
| 51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06120094 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05585590 |
| 53 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.05470483 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05188259 |
| 55 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04187973 |
| 56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03056421 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02052702 |
| 58 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00218101 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00042859 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99405212 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99236574 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98077480 |
| 63 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97589652 |
| 64 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97423057 |
| 65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96538141 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95819336 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93239399 |
| 68 | P300_27268052_Chip-Seq_Bcells_Human | 0.93158839 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92930923 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92615761 |
| 71 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.91903899 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.91902753 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.90980977 |
| 74 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90571457 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90130130 |
| 76 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89479861 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88284785 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88057765 |
| 79 | MAF_26560356_Chip-Seq_TH1_Human | 0.87209577 |
| 80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87022115 |
| 81 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.86165445 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85975203 |
| 83 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.85438962 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.85335080 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 0.85092399 |
| 86 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84929881 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84514072 |
| 88 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83535496 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83422821 |
| 90 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.82560769 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81844730 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81751163 |
| 93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80092628 |
| 94 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78110696 |
| 95 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78089430 |
| 96 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77445604 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75546424 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74901689 |
| 99 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74850884 |
| 100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74379638 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73853030 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73498028 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69987415 |
| 104 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.66934810 |
| 105 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66806230 |
| 106 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63228865 |
| 107 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62417028 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62075339 |
| 109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62053057 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61427862 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59559440 |
| 112 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58329773 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58060424 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58060424 |
| 115 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58055664 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57810916 |
| 117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.56429489 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53649762 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53540111 |
| 120 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53517312 |
| 121 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53281321 |
| 122 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.52744762 |
| 123 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52648286 |
| 124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51383582 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51058209 |
| 126 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.50308416 |
| 127 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49281503 |
| 128 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47649814 |
| 129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.47052262 |
| 130 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46472187 |
| 131 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45475233 |
| 132 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45114129 |
| 133 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45065837 |
| 134 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44378747 |
| 135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43522038 |
| 136 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43469265 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42450731 |
| 138 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42239743 |
| 139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41945356 |
| 140 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.41298587 |
| 141 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40181072 |
| 142 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39790997 |
| 143 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39756116 |
| 144 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39545594 |
| 145 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39274474 |
| 146 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.39198885 |
| 147 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.38941470 |
| 148 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.38904035 |
| 149 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.38503254 |
| 150 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.38147148 |
| 151 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.37783757 |
| 152 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.37271284 |
| 153 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.36847908 |
| 154 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.36581494 |
| 155 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.35771161 |
| 156 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34407501 |
| 157 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.33998355 |
| 158 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.33846027 |
| 159 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.33496686 |
| 160 | NCOR_22424771_ChIP-Seq_293T_Human | 0.32912206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.33809187 |
| 2 | MP0005360_urolithiasis | 7.50880166 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.44745507 |
| 4 | MP0005365_abnormal_bile_salt | 6.14391654 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.17113001 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.27907091 |
| 7 | MP0003252_abnormal_bile_duct | 3.86823194 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.64791755 |
| 9 | MP0009840_abnormal_foam_cell | 3.33853868 |
| 10 | MP0005083_abnormal_biliary_tract | 3.07372919 |
| 11 | MP0003195_calcinosis | 2.84325402 |
| 12 | MP0005332_abnormal_amino_acid | 2.73153783 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.55769172 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.38928629 |
| 15 | MP0000609_abnormal_liver_physiology | 2.16840887 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.11858952 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.11421564 |
| 18 | MP0009785_altered_susceptibility_to | 1.98231874 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.93534882 |
| 20 | MP0003868_abnormal_feces_composition | 1.88322376 |
| 21 | MP0003303_peritoneal_inflammation | 1.85728997 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.82227538 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.80645413 |
| 24 | MP0002419_abnormal_innate_immunity | 1.73678501 |
| 25 | MP0009697_abnormal_copulation | 1.70335007 |
| 26 | MP0001764_abnormal_homeostasis | 1.68910966 |
| 27 | MP0005025_abnormal_response_to | 1.65236885 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57603535 |
| 29 | MP0005671_abnormal_response_to | 1.52874563 |
| 30 | MP0005451_abnormal_body_composition | 1.50308954 |
| 31 | MP0003011_delayed_dark_adaptation | 1.46817649 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.43988461 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.37283749 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.33691038 |
| 35 | MP0003186_abnormal_redox_activity | 1.27804110 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.27769348 |
| 37 | MP0001790_abnormal_immune_system | 1.27643216 |
| 38 | MP0005387_immune_system_phenotype | 1.27643216 |
| 39 | MP0001800_abnormal_humoral_immune | 1.23363955 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.23179123 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.23179123 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.22850411 |
| 43 | MP0000598_abnormal_liver_morphology | 1.17813506 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.16693388 |
| 45 | MP0005647_abnormal_sex_gland | 1.16244708 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.12782721 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.11151364 |
| 48 | MP0000604_amyloidosis | 1.09290980 |
| 49 | MP0000685_abnormal_immune_system | 1.08968135 |
| 50 | MP0010368_abnormal_lymphatic_system | 1.08001977 |
| 51 | MP0002254_reproductive_system_inflammat | 1.07126199 |
| 52 | MP0009764_decreased_sensitivity_to | 1.06422107 |
| 53 | MP0009763_increased_sensitivity_to | 1.04780777 |
| 54 | MP0002723_abnormal_immune_serum | 1.02012281 |
| 55 | MP0002452_abnormal_antigen_presenting | 0.96028108 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 0.91979630 |
| 57 | MP0008469_abnormal_protein_level | 0.91138724 |
| 58 | MP0009642_abnormal_blood_homeostasis | 0.87948089 |
| 59 | MP0010155_abnormal_intestine_physiology | 0.87808197 |
| 60 | MP0002420_abnormal_adaptive_immunity | 0.86691709 |
| 61 | MP0001851_eye_inflammation | 0.86339146 |
| 62 | MP0001819_abnormal_immune_cell | 0.85622282 |
| 63 | MP0001533_abnormal_skeleton_physiology | 0.84920913 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 0.84242837 |
| 65 | MP0003879_abnormal_hair_cell | 0.82697618 |
| 66 | MP0005408_hypopigmentation | 0.82005847 |
| 67 | MP0005670_abnormal_white_adipose | 0.79592720 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 0.79101021 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 0.79043618 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.78987332 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 0.76929520 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.72594156 |
| 73 | MP0002971_abnormal_brown_adipose | 0.72579110 |
| 74 | MP0000689_abnormal_spleen_morphology | 0.71932869 |
| 75 | MP0005334_abnormal_fat_pad | 0.70384543 |
| 76 | MP0000343_altered_response_to | 0.69610502 |
| 77 | MP0004130_abnormal_muscle_cell | 0.67464700 |
| 78 | MP0005535_abnormal_body_temperature | 0.66646828 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 0.65677733 |
| 80 | MP0004147_increased_porphyrin_level | 0.64767423 |
| 81 | MP0003690_abnormal_glial_cell | 0.64541852 |
| 82 | MP0000716_abnormal_immune_system | 0.64251066 |
| 83 | MP0005266_abnormal_metabolism | 0.63092762 |
| 84 | MP0001661_extended_life_span | 0.62534945 |
| 85 | MP0003329_amyloid_beta_deposits | 0.61610498 |
| 86 | MP0001756_abnormal_urination | 0.61550000 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.61417717 |
| 88 | MP0004510_myositis | 0.60883132 |
| 89 | MP0009053_abnormal_anal_canal | 0.60760454 |
| 90 | MP0005464_abnormal_platelet_physiology | 0.60624850 |
| 91 | MP0000639_abnormal_adrenal_gland | 0.60406577 |
| 92 | MP0002405_respiratory_system_inflammati | 0.59982975 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.57799536 |
| 94 | MP0002282_abnormal_trachea_morphology | 0.55989018 |
| 95 | MP0005448_abnormal_energy_balance | 0.55219221 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.54072583 |
| 97 | MP0003724_increased_susceptibility_to | 0.50479252 |
| 98 | MP0002822_catalepsy | 0.49168806 |
| 99 | MP0003436_decreased_susceptibility_to | 0.48475124 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.47572814 |
| 101 | MP0005395_other_phenotype | 0.46099215 |
| 102 | MP0008874_decreased_physiological_sensi | 0.46048765 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.45870501 |
| 104 | MP0002928_abnormal_bile_duct | 0.44781212 |
| 105 | MP0008873_increased_physiological_sensi | 0.43915756 |
| 106 | MP0003718_maternal_effect | 0.43297924 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.42917018 |
| 108 | MP0003075_altered_response_to | 0.42067068 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.40949254 |
| 110 | MP0003953_abnormal_hormone_level | 0.40795472 |
| 111 | MP0005248_abnormal_Harderian_gland | 0.38101286 |
| 112 | MP0005166_decreased_susceptibility_to | 0.37764148 |
| 113 | MP0006082_CNS_inflammation | 0.36094890 |
| 114 | MP0000249_abnormal_blood_vessel | 0.36062481 |
| 115 | MP0004381_abnormal_hair_follicle | 0.35402948 |
| 116 | MP0009115_abnormal_fat_cell | 0.35290900 |
| 117 | MP0008872_abnormal_physiological_respon | 0.35230438 |
| 118 | MP0009672_abnormal_birth_weight | 0.33306725 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.32862993 |
| 120 | MP0001853_heart_inflammation | 0.31657421 |
| 121 | MP0000579_abnormal_nail_morphology | 0.31049846 |
| 122 | MP0004883_abnormal_blood_vessel | 0.30714942 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.30488399 |
| 124 | MP0002970_abnormal_white_adipose | 0.30483520 |
| 125 | MP0001845_abnormal_inflammatory_respons | 0.30220139 |
| 126 | MP0002796_impaired_skin_barrier | 0.29903025 |
| 127 | MP0001243_abnormal_dermal_layer | 0.29888036 |
| 128 | MP0002168_other_aberrant_phenotype | 0.28317251 |
| 129 | MP0001881_abnormal_mammary_gland | 0.25787164 |
| 130 | MP0005167_abnormal_blood-brain_barrier | 0.25265325 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.24047568 |
| 132 | MP0005164_abnormal_response_to | 0.23828868 |
| 133 | MP0002132_abnormal_respiratory_system | 0.21834302 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.21563504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.49181317 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.48112797 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.25330275 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.66380301 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.61851486 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.57299988 |
| 7 | Xanthomatosis (HP:0000991) | 6.26854728 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.70034473 |
| 9 | Complement deficiency (HP:0004431) | 5.30378409 |
| 10 | Joint hemorrhage (HP:0005261) | 4.96009809 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.87422662 |
| 12 | Hyperammonemia (HP:0001987) | 4.55143842 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.50059380 |
| 14 | Epidermoid cyst (HP:0200040) | 4.46272935 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.45053492 |
| 16 | Hyperglycinemia (HP:0002154) | 4.36540749 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.29804727 |
| 18 | Ketosis (HP:0001946) | 4.25579069 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.24587145 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22503433 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.11432215 |
| 22 | Fat malabsorption (HP:0002630) | 4.09184978 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.04920996 |
| 24 | Abnormality of complement system (HP:0005339) | 3.87910788 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83303222 |
| 26 | Hyperglycinuria (HP:0003108) | 3.82719628 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.82705948 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82705948 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.80664887 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.80219126 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.67442518 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.63730982 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37439784 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.35221108 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30267952 |
| 36 | Purpura (HP:0000979) | 3.23777828 |
| 37 | Spontaneous abortion (HP:0005268) | 3.16495342 |
| 38 | Steatorrhea (HP:0002570) | 3.10346747 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.09533890 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05177789 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.03279183 |
| 42 | Myocardial infarction (HP:0001658) | 3.02506716 |
| 43 | Ketoacidosis (HP:0001993) | 2.99967820 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.99884310 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.98104636 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.96828919 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.86922742 |
| 48 | Metabolic acidosis (HP:0001942) | 2.75627397 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.73095221 |
| 50 | Epistaxis (HP:0000421) | 2.72538302 |
| 51 | Skin nodule (HP:0200036) | 2.71597340 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.66115072 |
| 53 | Meningitis (HP:0001287) | 2.63319255 |
| 54 | Acanthocytosis (HP:0001927) | 2.63314637 |
| 55 | Vascular calcification (HP:0004934) | 2.62514704 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.58420271 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56334789 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.56334789 |
| 59 | Lethargy (HP:0001254) | 2.56275261 |
| 60 | Increased serum ferritin (HP:0003281) | 2.51529351 |
| 61 | Neonatal hypoglycemia (HP:0001998) | 2.48512525 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.47354926 |
| 63 | Glomerulonephritis (HP:0000099) | 2.47282639 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.45525832 |
| 65 | Gangrene (HP:0100758) | 2.45344935 |
| 66 | Spastic diplegia (HP:0001264) | 2.42650589 |
| 67 | Cholelithiasis (HP:0001081) | 2.42117571 |
| 68 | Mitral stenosis (HP:0001718) | 2.41319114 |
| 69 | Gout (HP:0001997) | 2.38893874 |
| 70 | Hypochromic anemia (HP:0001931) | 2.38040128 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.36160542 |
| 72 | Cholecystitis (HP:0001082) | 2.36160542 |
| 73 | Cerebral edema (HP:0002181) | 2.35960606 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34992918 |
| 75 | Malnutrition (HP:0004395) | 2.34729326 |
| 76 | Amyloidosis (HP:0011034) | 2.34141826 |
| 77 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33689751 |
| 78 | Obstructive lung disease (HP:0006536) | 2.33689751 |
| 79 | Gingival bleeding (HP:0000225) | 2.33668723 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.32492023 |
| 81 | Irritability (HP:0000737) | 2.32443670 |
| 82 | Neonatal onset (HP:0003623) | 2.31628152 |
| 83 | Cerebral palsy (HP:0100021) | 2.27648849 |
| 84 | Menorrhagia (HP:0000132) | 2.26689064 |
| 85 | Esophageal varix (HP:0002040) | 2.22731617 |
| 86 | Thrombophlebitis (HP:0004418) | 2.18071967 |
| 87 | Joint swelling (HP:0001386) | 2.14754469 |
| 88 | Myositis (HP:0100614) | 2.13464660 |
| 89 | Pancreatitis (HP:0001733) | 2.13176029 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 2.12598547 |
| 91 | Brushfield spots (HP:0001088) | 2.12449240 |
| 92 | Microcytic anemia (HP:0001935) | 2.11417881 |
| 93 | Late onset (HP:0003584) | 2.11288528 |
| 94 | Enlarged kidneys (HP:0000105) | 2.07953682 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.07267942 |
| 96 | Hemoptysis (HP:0002105) | 2.06001535 |
| 97 | Poikilocytosis (HP:0004447) | 2.05737179 |
| 98 | Vomiting (HP:0002013) | 2.05350628 |
| 99 | Orchitis (HP:0100796) | 2.03829164 |
| 100 | Retrobulbar optic neuritis (HP:0100654) | 2.03401918 |
| 101 | Optic neuritis (HP:0100653) | 2.03401918 |
| 102 | Opisthotonus (HP:0002179) | 2.01221910 |
| 103 | Abnormality of the gallbladder (HP:0005264) | 2.00737945 |
| 104 | Abnormality of macrophages (HP:0004311) | 1.99663215 |
| 105 | Generalized aminoaciduria (HP:0002909) | 1.99313150 |
| 106 | Eczematoid dermatitis (HP:0000976) | 1.98664927 |
| 107 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98656703 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 1.97439248 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92161850 |
| 110 | Dysostosis multiplex (HP:0000943) | 1.92155672 |
| 111 | Rickets (HP:0002748) | 1.89463091 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.87342824 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.87342824 |
| 114 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.87342824 |
| 115 | Renal cortical cysts (HP:0000803) | 1.86554796 |
| 116 | Recurrent bacterial skin infections (HP:0005406) | 1.85174172 |
| 117 | Elevated hepatic transaminases (HP:0002910) | 1.84878117 |
| 118 | Vasculitis (HP:0002633) | 1.84128359 |
| 119 | Anorexia (HP:0002039) | 1.83392286 |
| 120 | Hypophosphatemic rickets (HP:0004912) | 1.83090991 |
| 121 | Increased cerebral lipofuscin (HP:0011813) | 1.81943603 |
| 122 | Abnormal cartilage morphology (HP:0002763) | 1.81223670 |
| 123 | Pulmonary embolism (HP:0002204) | 1.80011484 |
| 124 | Abnormal platelet function (HP:0011869) | 1.79844449 |
| 125 | Impaired platelet aggregation (HP:0003540) | 1.79844449 |
| 126 | Status epilepticus (HP:0002133) | 1.79779505 |
| 127 | Hydroxyprolinuria (HP:0003080) | 1.78741063 |
| 128 | Abnormality of proline metabolism (HP:0010907) | 1.78741063 |
| 129 | Fair hair (HP:0002286) | 1.78649403 |
| 130 | Nephritis (HP:0000123) | 1.77136537 |
| 131 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76350571 |
| 132 | Alkalosis (HP:0001948) | 1.75947844 |
| 133 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.75894438 |
| 134 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75894438 |
| 135 | Abnormality of glycolipid metabolism (HP:0010969) | 1.75894438 |
| 136 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.75859711 |
| 137 | Mucopolysacchariduria (HP:0008155) | 1.75769248 |
| 138 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.75769248 |
| 139 | Arterial thrombosis (HP:0004420) | 1.74582488 |
| 140 | Gingivitis (HP:0000230) | 1.72585305 |
| 141 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.72114325 |
| 142 | Reticulocytosis (HP:0001923) | 1.71262761 |
| 143 | Osteomalacia (HP:0002749) | 1.69643093 |
| 144 | Pulmonary infiltrates (HP:0002113) | 1.69353613 |
| 145 | Atrioventricular block (HP:0001678) | 1.68264208 |
| 146 | Abnormality of the prostate (HP:0008775) | 1.65569315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.09629217 |
| 2 | FGFR4 | 4.67036407 |
| 3 | SIK1 | 4.57518459 |
| 4 | ERN1 | 4.28106071 |
| 5 | RIPK4 | 3.30262751 |
| 6 | TAOK3 | 3.13227869 |
| 7 | INSRR | 3.00680602 |
| 8 | TNK2 | 2.87813855 |
| 9 | ERBB4 | 2.77406260 |
| 10 | FES | 2.76272118 |
| 11 | PKN2 | 2.26552953 |
| 12 | MAP2K4 | 2.23845266 |
| 13 | MST1R | 2.00426963 |
| 14 | FLT3 | 1.91238269 |
| 15 | MAPK11 | 1.79783013 |
| 16 | CDK19 | 1.77586819 |
| 17 | PIK3CG | 1.77368950 |
| 18 | TYK2 | 1.75912896 |
| 19 | NTRK3 | 1.73179652 |
| 20 | TRIB3 | 1.72220146 |
| 21 | SYK | 1.66171140 |
| 22 | PRPF4B | 1.63387432 |
| 23 | DAPK2 | 1.60024342 |
| 24 | IRAK4 | 1.59443411 |
| 25 | KDR | 1.51052454 |
| 26 | PTK6 | 1.48839147 |
| 27 | CAMKK2 | 1.42221356 |
| 28 | BTK | 1.41370531 |
| 29 | ABL2 | 1.35859862 |
| 30 | MARK3 | 1.32316696 |
| 31 | LATS1 | 1.31132650 |
| 32 | PINK1 | 1.28571716 |
| 33 | JAK2 | 1.25396506 |
| 34 | NEK9 | 1.22967796 |
| 35 | FGFR2 | 1.21569589 |
| 36 | JAK3 | 1.20704530 |
| 37 | LYN | 1.15857489 |
| 38 | GRK6 | 1.15096824 |
| 39 | FRK | 1.14296130 |
| 40 | IKBKB | 1.13915045 |
| 41 | MAP2K3 | 1.13816000 |
| 42 | MAP3K7 | 1.11670832 |
| 43 | CAMKK1 | 1.11198439 |
| 44 | TBK1 | 1.10154612 |
| 45 | MAP3K11 | 1.09216113 |
| 46 | PRKAA2 | 1.07612094 |
| 47 | MATK | 1.06539354 |
| 48 | JAK1 | 1.03149751 |
| 49 | TIE1 | 1.03115244 |
| 50 | MAP3K14 | 1.02180472 |
| 51 | MAPK4 | 1.00910280 |
| 52 | TEC | 0.94917067 |
| 53 | TESK2 | 0.94177712 |
| 54 | EPHB1 | 0.94144611 |
| 55 | ERBB2 | 0.93607397 |
| 56 | TAOK1 | 0.92847949 |
| 57 | TXK | 0.92384848 |
| 58 | MAPK12 | 0.92085689 |
| 59 | MAPK15 | 0.92085286 |
| 60 | STK16 | 0.90242453 |
| 61 | TGFBR2 | 0.88585612 |
| 62 | STK11 | 0.87640637 |
| 63 | MAP4K2 | 0.86361876 |
| 64 | PTK2B | 0.85855864 |
| 65 | MAP3K3 | 0.85559013 |
| 66 | PRKCZ | 0.85460721 |
| 67 | EPHA3 | 0.85177777 |
| 68 | MAP3K10 | 0.85173471 |
| 69 | CDK6 | 0.85006456 |
| 70 | GRK7 | 0.83814980 |
| 71 | HCK | 0.82696892 |
| 72 | LCK | 0.82319876 |
| 73 | RIPK1 | 0.80835198 |
| 74 | RPS6KA2 | 0.78088385 |
| 75 | ARAF | 0.75684011 |
| 76 | SIK2 | 0.75055173 |
| 77 | MET | 0.74423517 |
| 78 | FGR | 0.74028273 |
| 79 | MAPK7 | 0.73389559 |
| 80 | ADRBK2 | 0.73370575 |
| 81 | PRKACG | 0.73126613 |
| 82 | CSK | 0.71873272 |
| 83 | STK38L | 0.71537216 |
| 84 | CAMK1D | 0.71494903 |
| 85 | DYRK1B | 0.71341309 |
| 86 | MAP2K6 | 0.68715296 |
| 87 | RPS6KC1 | 0.66903395 |
| 88 | RPS6KL1 | 0.66903395 |
| 89 | RPS6KA6 | 0.66713923 |
| 90 | ITK | 0.66358265 |
| 91 | CAMK2G | 0.65226812 |
| 92 | CSF1R | 0.64565939 |
| 93 | DAPK1 | 0.63437792 |
| 94 | PRKAA1 | 0.63346503 |
| 95 | MAP3K13 | 0.62651322 |
| 96 | GSK3A | 0.61352643 |
| 97 | SGK3 | 0.60514745 |
| 98 | PDK3 | 0.59540277 |
| 99 | PDK4 | 0.59540277 |
| 100 | MAP4K1 | 0.59262567 |
| 101 | IKBKE | 0.58039947 |
| 102 | PTK2 | 0.57108506 |
| 103 | CSNK1G1 | 0.56771149 |
| 104 | FGFR3 | 0.55704861 |
| 105 | PDPK1 | 0.54029973 |
| 106 | ICK | 0.53985109 |
| 107 | PIM1 | 0.53393485 |
| 108 | CDK4 | 0.51003231 |
| 109 | OXSR1 | 0.47940691 |
| 110 | GRK1 | 0.47428867 |
| 111 | PRKCQ | 0.47383854 |
| 112 | HIPK2 | 0.45586097 |
| 113 | IRAK3 | 0.44363630 |
| 114 | IGF1R | 0.43411111 |
| 115 | FYN | 0.42686793 |
| 116 | MARK2 | 0.42206943 |
| 117 | ABL1 | 0.41016784 |
| 118 | PRKACA | 0.39883581 |
| 119 | PRKCG | 0.39664474 |
| 120 | PRKD2 | 0.39503080 |
| 121 | SGK2 | 0.39256437 |
| 122 | EPHA4 | 0.39227275 |
| 123 | KSR1 | 0.38656552 |
| 124 | PDK1 | 0.38558585 |
| 125 | MAP3K1 | 0.36995539 |
| 126 | TAOK2 | 0.36995153 |
| 127 | CSNK1G3 | 0.36926883 |
| 128 | RET | 0.36678953 |
| 129 | MAP2K1 | 0.36677214 |
| 130 | PRKG1 | 0.36322393 |
| 131 | CAMK1G | 0.36064649 |
| 132 | CSNK1G2 | 0.35328167 |
| 133 | MAP3K6 | 0.34911673 |
| 134 | MAPK3 | 0.34645460 |
| 135 | BLK | 0.34248297 |
| 136 | KIT | 0.33998566 |
| 137 | MAP3K5 | 0.33835049 |
| 138 | EGFR | 0.33418928 |
| 139 | CHUK | 0.33289165 |
| 140 | PKN1 | 0.30829270 |
| 141 | CAMK4 | 0.30531163 |
| 142 | MTOR | 0.29913375 |
| 143 | MAP2K2 | 0.26054512 |
| 144 | IRAK1 | 0.24812596 |
| 145 | PRKCA | 0.24020064 |
| 146 | CSNK1A1L | 0.23034051 |
| 147 | SGK494 | 0.22475343 |
| 148 | SGK223 | 0.22475343 |
| 149 | ZAP70 | 0.22039812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54821658 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.52517904 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38694178 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.33345973 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04327711 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80199477 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73209867 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67866169 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62068104 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52741004 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50239776 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36647442 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25130366 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14926110 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13595601 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09431923 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97750347 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95131558 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92885227 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92811464 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92423045 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88079525 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81415826 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80295116 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77629269 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73798398 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73235394 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71445176 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70228739 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65112864 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63811818 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58708449 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53645258 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51977825 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.48834941 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45976495 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42664853 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38568593 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34376470 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32408711 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31829825 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29719067 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28925882 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.21955791 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18024633 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16598203 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16530292 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11091372 |
| 49 | Asthma_Homo sapiens_hsa05310 | 1.07799918 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02358878 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00972916 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00354608 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98168660 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95619721 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95549516 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95030891 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93572522 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87569667 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84001450 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81725911 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.79855034 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73555276 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73259483 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67847756 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64640349 |
| 66 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61372766 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 0.61350327 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57763064 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55586012 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53546055 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51330783 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51019613 |
| 73 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49815904 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45546861 |
| 75 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44545263 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43231132 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38682943 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.38489832 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.35362350 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.34635220 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.32069111 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32054622 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32037295 |
| 84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29938808 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28631618 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27508438 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24492467 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.24121474 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.24064731 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22738522 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.21552998 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.20969208 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20387701 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.18768408 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17849915 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15333886 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12697316 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10434749 |
| 99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.09213553 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.08925953 |
| 101 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.06881146 |
| 102 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.06237260 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03562358 |
| 104 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.03258445 |
| 105 | Pertussis_Homo sapiens_hsa05133 | -0.2326678 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2230194 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2155541 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2154647 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2104118 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2084878 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2056137 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2018801 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1941373 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | -0.1853416 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1619503 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1501192 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1496803 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1458203 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1451238 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1245204 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1176623 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1070683 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0971417 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0486569 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0329821 |
| 126 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0107603 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | -0.0033449 |

